Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer’s Disease in Mice-Reference-Cited by-同舟云学术

Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer’s Disease in Mice

Published:2019-08-27 Issue:10 Volume:30 Page:2573-2583
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Gothwal Avinash¹,Kumar Hitesh¹,Nakhate Kartik T.²,Ajazuddin ²,Dutta Ankumoni³,Borah Anupom³,Gupta Umesh¹^ORCID

Affiliation:

1. Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Ajmer, Rajasthan 305817 India

2. Rungta College of Pharmaceutical Sciences and Research, Kohka Road, Kurud, Bhilai, Chhattisgarh 490024, India

3. Cellular and Molecular Neurobiology Laboratory, Department of Life Science and Bioinformatics, Assam University, Silchar, Assam 788011, India

Funder

University Grants Commission

Department of Science and Technology, Ministry of Science and Technology

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.9b00505

Reference38 articles.

1. The Global Impact of Dementia 2013–2050, Alzheimer’s disease international.

2. Alzheimer’s Disease Facts and Figures 2018, fact sheet, Alzheimer’s impact movement.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems;AAPS PharmSciTech;2024-09-05

2. Dendrimers—Novel Therapeutic Approaches for Alzheimer’s Disease;Biomedicines;2024-08-20

3. Current Overview on the Use of Nanosized Drug Delivery Systems in the Treatment of Neurodegenerative Diseases;ACS Omega;2024-08-05

4. Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability;Advanced Science;2024-08-05

5. Development of nanomedicines for the treatment of Alzheimer’s disease: Raison d’être, strategies, challenges and regulatory aspects;Ageing Research Reviews;2024-07